[Severe disseminated Mycobacterium bovis BCG infection as a consequence of intravesical BCG therapy: diagnostic challenges and therapeutic options].
We present the case of a 65-year-old patient with superficial carcinoma of the bladder who developed systemic inflammatory reaction as a result of a severe disseminated infection with M. bovis BCG after intravesical instillation of BCG. Besides the recommended antituberculosis therapy, considering the resistance of M. bovis to PZA, we discuss here the option of using steroids in the therapeutic management of this patient.
Medizinische Klinik III, Krankenhaus Bethanien, Moers.
P
P
Stais
Medizinische Klinik III, Krankenhaus Bethanien, Moers.
K
K
Kambartel
Medizinische Klinik III, Krankenhaus Bethanien, Moers.
A
A
Yildirim
Medizinische Klinik III, Krankenhaus Bethanien, Moers.
T
T
Voshaar
D000283:Administration, Intravesical; D000368:Aged; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009163:Mycobacterium bovis / Q000302:isolation & purification*; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology* / Q000382:microbiology*; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy*
D000995:Antitubercular Agents; D001500:BCG Vaccine